Stability Indicating RP-UPLC Method Development & Validation for Quantitation of Doravirine in Tablet Formulation . Journal of Pharmaceutical Negative Results, [S. l.], v. 13, n. 4, p. 1776–1782, 2023. DOI: 10.47750/pnr.2022.13.04.243. Disponível em: https://pnrjournal.com/index.php/home/article/view/5956.. Acesso em: 5 jun. 2026.